MORE THAN HEALTH ON LINE IN PATENT DEBATE
Investors will attest that IP is at the core of any life sciences company valuation, and as such, the life of the patent and the data exclusivity once a company gets their product to market is of paramount importance when assessing an investment's potential.
Saved in:
Published in | Herald-Sun news-pictorial |
---|---|
Main Author | |
Format | Newspaper Article |
Language | English |
Published |
Melbourne, Vic
Nationwide News Pty Ltd
23.09.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Investors will attest that IP is at the core of any life sciences company valuation, and as such, the life of the patent and the data exclusivity once a company gets their product to market is of paramount importance when assessing an investment's potential. |
---|---|
ISSN: | 1038-3433 |